RSPH Invesco S&P 500 Equal Weight Health Care ETF
Quote as of Oct 09, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 36.96 | Day Range | 37.00 – 37.65 |
| 52-Week Range | 29.46 – 38.19 | Volume | 166.35K |
| Avg Volume | 152.17K | AUM | $880.5M (Oct 10, 2026) |
| Expense Ratio | 0.40% | Yield (TTM) | 0.59% |
| NAV | 36.98 | Premium/Discount | +1.65% indicative |
| Inception | Nov 01, 2006 | Holdings | 61 |
| Issuer | Invesco | Exchange | AMEX |
| Category | Healthcare | Index Tracked | S&P 500 |
| CUSIP | 46137V332 | ISIN | US46137V3327 |
| Management | Passive / index-tracking (per issuer description) | ||
About this ETF
The Invesco S&P 500 Equal Weight Health Care ETF aims to track the performance of the S&P 500 Equal Weight Health Care Index. This fund primarily allocates a minimum of 90% of its total assets to the common stocks that constitute its underlying benchmark. The Index itself assigns an equal weighting to all healthcare sector companies that are part of the broader S&P 500 Index. Both the ETF and the Index undergo a portfolio adjustment process on a quarterly basis.
Description from the fund data provider · profile as of Oct 10, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +3.55% | +10.62% | +23.04% | +18.02% | +24.84% | +10.76% | +4.89% | +9.53% | +10.60% |
| Total return | +3.55% | +10.62% | +23.29% | +18.47% | +25.51% | +11.48% | +5.59% | +10.19% | +11.24% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.40% | Annual cost of a $10,000 investment | $40.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 65 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 2.67% | 105.59K | $23.8M |
| 2 | Illumina Inc | ILMN | 2.18% | 69.86K | $19.4M |
| 3 | Revvity Inc | PKI | 2.00% | 115.59K | $17.8M |
| 4 | Mettler-Toledo International Inc | MTD | 1.93% | 11.10K | $17.2M |
| 5 | Intuitive Surgical Inc | ISRG | 1.93% | 40.53K | $17.2M |
| 6 | Agilent Technologies Inc | A | 1.90% | 98.93K | $16.9M |
| 7 | Veeva Systems Inc | VEEV | 1.83% | 54.93K | $16.3M |
| 8 | AbbVie Inc | ABBV | 1.77% | 57.07K | $15.8M |
| 9 | Thermo Fisher Scientific Inc | TMO | 1.75% | 23.64K | $15.6M |
| 10 | West Pharmaceutical Services Inc | WST | 1.75% | 42.50K | $15.6M |
| 11 | Charles River Laboratories International Inc | CRL | 1.74% | 51.40K | $15.5M |
| 12 | Humana Inc | HUM | 1.73% | 35.76K | $15.4M |
| 13 | Danaher Corp | DHR | 1.73% | 69.93K | $15.4M |
| 14 | Waters Corp | WAT | 1.72% | 35.38K | $15.3M |
| 15 | Biogen Inc | BIIB | 1.72% | 67.90K | $15.3M |
| 16 | Viatris Inc | VTRS | 1.72% | 867.97K | $15.3M |
| 17 | HCA Healthcare Inc | HCA | 1.72% | 33.90K | $15.3M |
| 18 | Amgen Inc | AMGN | 1.70% | 36.59K | $15.2M |
| 19 | McKesson Corp | MCK | 1.69% | 16.05K | $15.1M |
| 20 | Eli Lilly & Co | LLY | 1.68% | 12.71K | $15.0M |
| 21 | ResMed Inc | RMD | 1.68% | 65.13K | $15.0M |
| 22 | Elevance Health Inc | ANTM | 1.67% | 36.03K | $14.9M |
| 23 | Gilead Sciences Inc | GILD | 1.67% | 98.27K | $14.9M |
| 24 | Becton Dickinson & Co | BDXA | 1.64% | 79.66K | $14.6M |
| 25 | Centene Corp | CNC | 1.64% | 223.55K | $14.6M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.59% | Paid (last 12 months) | $0.2234 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 21, 2026 | Last payment | $0.0516 (Sep 25, 2026) |
| Growth 1Y | -1.72% | Growth 3Y / 5Y (ann.) | -46.99% / -30.31% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 21, 2026 | Sep 21, 2026 | Sep 25, 2026 | $0.0516 |
| Jun 22, 2026 | Jun 22, 2026 | Jun 26, 2026 | $0.0627 |
| Mar 23, 2026 | Mar 23, 2026 | Mar 27, 2026 | $0.0561 |
| Dec 22, 2025 | Dec 22, 2025 | Dec 26, 2025 | $0.0530 |
| Sep 22, 2025 | Sep 22, 2025 | Sep 26, 2025 | $0.0599 |
| Jun 23, 2025 | Jun 23, 2025 | Jun 27, 2025 | $0.0555 |
| Mar 24, 2025 | Mar 24, 2025 | Mar 28, 2025 | $0.0551 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 27, 2024 | $0.0569 |
| Sep 23, 2024 | Sep 23, 2024 | Sep 27, 2024 | $0.0547 |
| Jun 24, 2024 | Jun 24, 2024 | Jun 28, 2024 | $0.0508 |
| Mar 18, 2024 | Mar 19, 2024 | Mar 22, 2024 | $0.0459 |
| Dec 18, 2023 | Dec 19, 2023 | Dec 22, 2023 | $0.0499 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 16.52% / 16.08% | Sharpe 1Y / 3Y | 1.56 / 0.593 |
| Max drawdown 1Y / 3Y | -10.89% / -17.12% | Sortino 1Y | 2.62 |
| Beta vs S&P 500 (3Y) | 0.581 | Correlation vs S&P 500 (1Y) | 0.35 |
| Downside deviation 1Y | 9.84% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 11, 2026. Formulas →
Liquidity
| Volume today | 166.35K | Average volume | 152.17K |
| AUM | $880.5M | Premium/Discount | +1.65% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$5.6M | -0.63% | $886.1M → $880.5M |
| 1 Month | $6.5M | +0.78% | $838.9M → $880.5M |
| 1 Week | -$13.3M | -1.53% | $870.7M → $880.5M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for RSPH
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.